A New Treatment for Head and Neck Cancer
November 20, 2026
November 20, 2026
NEW HAVEN, Connecticut, Nov. 20 -- The Yale University School of Medicine issued the following news:
* * *
A New Treatment for Head and Neck Cancer
*
On Nov. 5, the U.S. Food and Drug Administration (FDA) approved the use of a new drug to treat head and neck cancer, the first in seven years. Called amivantamab, the drug is the first to target two growth receptors for head and neck cancer simultaneously, reducing the cancer's ability to ada . . .
* * *
A New Treatment for Head and Neck Cancer
*
On Nov. 5, the U.S. Food and Drug Administration (FDA) approved the use of a new drug to treat head and neck cancer, the first in seven years. Called amivantamab, the drug is the first to target two growth receptors for head and neck cancer simultaneously, reducing the cancer's ability to ada . . .
